Mellett Paul J

Avg. Two Year Performance

No purchase track record

33% Avg. Sale Return

15% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	1%	7%	18%	16%	33%
Sale Success Rate	7 of 16	9 of 16	13 of 16	9 of 16	11 of 16

Enanta Pharmaceuticals Inc

Drugs » Biotechnology

Chief Fin. & Admin Officer:

Holdings: 95.9K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--